Format:
Online-Ressource (XVI, 462p. 11 illus., 5 illus. in color, digital)
ISBN:
9789400708341
Series Statement:
SpringerLink
Content:
A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment, suspected neuropathology, and treatment of these disorders. Recent technological breakthroughs in basic sciences hold promise for advancing our understanding of the pathophysiology of schizophrenia spectrum disorders. This collective monograph reviewers recent researches regarding the origins, onset, course, and outcome of schizophrenia spectrum disorders. In particular, this book will be illustrate new developments in terms of conceptual models, and research methodology, genetics and genomics, brain imaging and neurochemical studies, neurophysiology and information processing in schizophrenia spectrum disorders patients. Also will be highlighted new developments in our understanding of the childhood psychosis, prodromal and first-episode states, in treatment and rehabilitation. Thus, the purpose of this book is to provide up-to-date overview of the rapid advances made in the clinical and basic science studies supporting our understanding of the relationship between cerebral processes and clinical, cognitive and other presentations of the schizophrenia spectrum disorders. In addition, this book aims to monitor important research developments, which may be relevant to treatment, and rehabilitation of patients.
Note:
Includes bibliographical references and index
,
Foreword; Schizophrenia Spectrum Disorders: Insights from Views Across 100 years; Contents; Contributors; 1 Recovery in Schizophrenia: Perspectives, Evidence, and Implications; Introduction; What Is Recovery?; Part I: The Medical Model of Recovery; Part II: The Consumer Model of Recovery; SAMHSA Recovery Domains; Qualitative Studies of the Consumer Conception of Recovery; Part III: Integrating Medical and Consumer Models of Recovery; Part IV: Implications of the Consumer Model of Recovery for Practice, Education, and Research; Implications for Practice; Implications for Education
,
Implications for ResearchConclusions; References; 2 The Magic Shotgun: Does It Fit the Clinician and Will It Point at Schizophrenia?; Introduction; Taking the Analogy Further; Mechanisms of Action and ""Pipeline"" Antipsychotic Drugs; Dopamine Receptors; Glutamate Receptors; Muscarinic Receptors; Serotonin Receptors; Other Potential Substrates for Antipsychotic Action; Current Approximations to the Magic Shotgun: Are They Any Good?; More than One Antipsychotic Drug; Augmentation with Other Psychotropic Drug Classes; Mood Stabilizers: Lithium and Anticonvulsant Drugs; Antidepressant Drugs
,
BenzodiazepinesAnti-dementia Drugs; Drugs for Substance Abuse; Atomoxetine; Augmentation and Supplementation on a Theoretical Basis; Purinergic Drugs; Anti Inflammatory/Immunological Drugs; Sexual Hormones; Antihistaminergic Drugs; Serotonin Antagonism; Cortisol Antagonism; Nitric Oxide Deficiency; Retinoid Dysregulation; Miscellaneous; Olanzapine; Mirtazapine; Modafinil; Selegiline; Pergolide; Valacyclovir; S-Adenosyl Methionine; Ginkgo Biloba; N-Acetyl Cysteine; Vitamin C; Integrating Multiple Mechanisms; Conclusions and Future Directions; References
,
3 Advancing Neuroprotective-Based Treatments for SchizophreniaIntroduction; Neuroprotective Treatment Strategy; Neurosteroids as Neuroprotective Agents; Clinical Trials with Neurosteroids; Vitamins as Neuroprotective Agents; Clinical Trials with Vitamins; Vitamin A; Vitamin B6 (Pyridoxine); Vitamin C (Ascorbic Acid); Vitamin D; Vitamin E (α-Tocoferol); Vitamin B12 and Folic Acid; Omega -3; Ginkgo Biloba; L-theanine; Conclusions and Future Directions; References; 4 Prevention and Early Intervention in At-Risk States for Developing Psychosis; Introduction; Prevention Studies
,
Prevention Studies Focusing on Pharmacological InterventionRandomized Controlled Trials of Antipsychotics; Naturalistic Treatment Study of Antipsychotics and Antidepressants; Neuroprotective Treatment Trials; Prevention Studies Focusing on Psychotherapy; Treatment Approaches; Conclusions and Future Directions; References; 5 Early Improvement and Its Predictive Validity in First-Episode Schizophrenia Patients; Introduction; Early Improvement in FES Patients and Its Predictive Validity Regarding Outcome; Clinical Data; General Aspects on Early Improvement in FES Patients
,
Antipsychotic Treatment and Early Improvement
Additional Edition:
ISBN 9789400708334
Additional Edition:
Buchausg. u.d.T. ISBN 978-94-007-0833-4
Language:
English
DOI:
10.1007/978-94-007-0834-1
URL:
Volltext
(lizenzpflichtig)
Bookmarklink
